Cargando…
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia
There is an urgent need for new antimicrobials to treat the opportunistic Gram-negative Burkholderia cenocepacia, which represents a problematic challenge for cystic fibrosis patients. Recently, a benzothiadiazole derivative, C109, was shown to be effective against the infections caused by B. cenoce...
Autores principales: | Chiarelli, Laurent R., Scoffone, Viola Camilla, Trespidi, Gabriele, Barbieri, Giulia, Riabova, Olga, Monakhova, Natalia, Porta, Alessio, Manina, Giulia, Riccardi, Giovanna, Makarov, Vadim, Buroni, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154053/ https://www.ncbi.nlm.nih.gov/pubmed/32318042 http://dx.doi.org/10.3389/fmicb.2020.00562 |
Ejemplares similares
-
Molecular Characterization of the Burkholderia cenocepacia
dcw Operon and FtsZ Interactors as New Targets for Novel Antimicrobial Design
por: Trespidi, Gabriele, et al.
Publicado: (2020) -
Antistaphylococcal Activity of the FtsZ Inhibitor C109
por: Trespidi, Gabriele, et al.
Publicado: (2021) -
Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against Acinetobacter baumannii
por: Scoffone, Viola Camilla, et al.
Publicado: (2022) -
Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
por: Scoffone, Viola C., et al.
Publicado: (2017) -
Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ
por: Hogan, Andrew M., et al.
Publicado: (2018)